This document summarizes the key points of a plasma master file (PMF). A PMF contains all required scientific data on the quality and safety of human plasma used to manufacture medicines, medical devices, and investigational products. It was introduced by the European Union in 2003 to simplify regulatory submissions and ensure consistent evaluation of plasma quality across countries. The certification process involves submitting an application to the European Medicines Agency, which appoints coordinators to evaluate the PMF and issue a certificate valid throughout the EU if compliance is demonstrated. Changes to plasma or products listed in the PMF require recertification through this centralized procedure.